Case Control Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Feb 28, 2019; 25(8): 967-979
Published online Feb 28, 2019. doi: 10.3748/wjg.v25.i8.967
Table 3 Histopathological reassessment n (%)
Parameter (n = 28)Drug-induced colitis without atherosclerosisDrug-induced colitis with atherosclerosisIschaemiccolitis
Oedema2 (7.1)2 (7.1)4 (14.3)
Haemorrhage1 (3.6)a28 (28.6)a16 (21.4)
Lymphocytic infiltration27 (96.4)27 (96.4)27 (96.4)
Granulocytic infiltration27 (96.4)26 (92.9)28 (100.0)
Eosinophilic infiltration12 (42.9)b27 (25.0)1 (3.6)a3
Erosions2 (7.1)b29 (32.1)a110 (35.7)
Ulcerous lesions4 (14.3)b23 (10.7)16 (57.1)b3
Necrosis1 (3.6)b21 (3.6)16 (57.1)b3
Fibrin plaques on erosions2 (7.1)2 (7.1)3 (10.7)
Fibrosis3 (10.7)3 (10.7)7 (25.0)